{"id":44228,"date":"2022-05-23T18:01:18","date_gmt":"2022-05-23T16:01:18","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/median-technologies-announces-the-availability-of-the-preparatory-documents-for-the-shareholders-ordinary-and-extraordinary-general-meeting-on-june-14-2022\/"},"modified":"2022-05-23T18:01:18","modified_gmt":"2022-05-23T16:01:18","slug":"median-technologies-announces-the-availability-of-the-preparatory-documents-for-the-shareholders-ordinary-and-extraordinary-general-meeting-on-june-14-2022","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/median-technologies-announces-the-availability-of-the-preparatory-documents-for-the-shareholders-ordinary-and-extraordinary-general-meeting-on-june-14-2022\/","title":{"rendered":"Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders\u2019 Ordinary and Extraordinary General Meeting on June 14, 2022"},"content":{"rendered":"<div>\n<p>SOPHIA ANTIPOLIS, France&#8211;(BUSINESS WIRE)&#8211;Regulatory News:\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220523005724\/en\/1343975\/5\/Median_RGB.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220523005724\/en\/1343975\/21\/Median_RGB.jpg\"><\/a><\/p>\n<p>\nThe shareholders of Median Technologies (ALMDT:PA) are invited to participate at the Shareholders\u2019 Ordinary and Extraordinary General Meeting which will be held on Tuesday June 14, 2022, at 5:00 PM at PDGB, 174 avenue Victor Hugo \u2013 75116 Paris.\n<\/p>\n<p>\nAll useful information relating to this Shareholders\u2019 General Meeting is regularly updated on Median Technologies\u2019 website.\n<\/p>\n<p>\nShareholders may exercise their voting rights before the holding of the Shareholders\u2019 General Meeting, either by returning their postal voting form, or by giving proxy. The detailed procedures relating to the exercise of the right to vote are specified in the notice of the Shareholders\u2019 General Meeting, available <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fmediantechnologies.com%2Fwp-content%2Fuploads%2F2022%2F05%2FNotice-of-Ordinary-and-Extraordinary-General-Meeting-dated-June-14-2022-in-French-only.pdf&amp;esheet=52727976&amp;newsitemid=20220523005724&amp;lan=en-US&amp;anchor=here&amp;index=1&amp;md5=a3a6d8adf729af773c46c4f8920736d0\" rel=\"nofollow noopener\" shape=\"rect\">here<\/a> on Median\u2019s website\n<\/p>\n<p>\nThe preliminary notice of the Shareholders\u2019 General Meeting has been published in the BALO (<i>Bulletin des annonces l\u00e9gales obligatoires<\/i>) on May 6, 2022.\n<\/p>\n<p>\nThe documents referred to in Article R.225-83 of the French Commercial Code are made available to Shareholders as from the date of the convening notice for the Meeting in accordance with applicable regulations:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nRegistered shareholders may, up to and including the fifth day prior to the Meeting, request that the company sends these documents to them free of charge. For shareholders holding bearer shares, the exercise of this right is subject to the provision of a certificate of registration in the accounts of the bearer shares issued by the authorized intermediary;\n<\/li>\n<li>\nShareholders may consult these documents at the company\u2019s registered office, Les 2 Arcs, 1800 route des Cr\u00eates \u2013 06560 Valbonne, under the conditions provided for by applicable regulations.\n<\/li>\n<\/ul>\n<p>\nThe documents to be communicated within the context of the Shareholders\u2019 General Meeting may be consulted and downloaded on Median Technologies\u2019 website under the \u201cShareholder Meetings\u201d section <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fmediantechnologies.com%2Finvestors%2Fpress-releases-reports-presentations-shareholder-meetings%2F&amp;esheet=52727976&amp;newsitemid=20220523005724&amp;lan=en-US&amp;anchor=here&amp;index=2&amp;md5=7a1dbf4882a77e03849da1b66f8e17b6\" rel=\"nofollow noopener\" shape=\"rect\">here<\/a>.\n<\/p>\n<p>\n<strong>About Median Technologies:<\/strong><b> <\/b><strong>About Median Technologies:<\/strong><b> <\/b>Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. We harness the power of medical images by using the most advanced Artificial Intelligence technologies, to increase the accuracy of diagnosis and treatment of many cancers and other metabolic diseases at their earliest stages and provide insights into novel therapies for patients. Our iCRO solutions for medical image analysis and management in oncology trials and iBiopsy\u00ae, our AI-powered software as medical device help biopharmaceutical companies and clinicians to bring new treatments and diagnose patients earlier and more accurately. This is how we are helping to create a healthier world.\n<\/p>\n<p>\nFounded in 2002, based in Sophia-Antipolis, France, with a subsidiary in the US and another one in Shanghai, Median has received the label \u201cInnovative company\u201d by the BPI and is listed on Euronext Growth market (Paris). FR0011049824\u2013 ticker: ALMDT. Median is eligible for the French SME equity savings plan scheme (PEA-PME), is part of the Enternext\u00ae PEA-PME 150 index and has been awarded the Euronext European Rising Tech label. For more information: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.mediantechnologies.com%2F&amp;esheet=52727976&amp;newsitemid=20220523005724&amp;lan=en-US&amp;anchor=www.mediantechnologies.com&amp;index=3&amp;md5=526ff6dfce7b4c4f1da2242bb9aa1c4e\" rel=\"nofollow noopener\" shape=\"rect\">www.mediantechnologies.com<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Median Technologies<\/b><br \/>Emmanuelle Leygues<br \/>\n<br \/>Head of Corporate Marketing &amp; Financial Communications<br \/>\n<br \/>+33 6 10 93 58 88<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;a&#x69;l&#x74;o&#x3a;e&#x6d;&#109;&#x61;&#110;&#x75;&#101;&#x6c;&#108;e&#46;l&#x65;y&#x67;u&#x65;&#115;&#x40;&#109;&#x65;&#100;&#x69;&#97;&#x6e;&#116;e&#99;h&#x6e;o&#x6c;o&#x67;&#105;&#x65;&#115;&#x2e;&#99;&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">e&#109;&#109;&#x61;&#x6e;&#x75;e&#108;&#108;&#x65;&#x2e;&#x6c;ey&#103;&#x75;&#x65;&#x73;&#64;m&#101;&#100;&#x69;&#x61;&#x6e;t&#101;&#99;&#x68;&#x6e;&#x6f;l&#111;&#103;&#x69;&#x65;&#x73;&#46;c&#111;&#x6d;<\/a>\n<\/p>\n<p>\n<b>Press &#8211; ALIZE RP<\/b><br \/>Caroline Carmagnol<br \/>\n<br \/>+33 6 64 18 99 59<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#97;&#105;l&#x74;&#x6f;&#58;m&#x65;&#x64;&#105;an&#x40;&#97;&#108;i&#x7a;&#x65;&#114;p&#x2e;&#x63;&#111;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">me&#100;&#105;&#97;&#110;&#x40;&#x61;&#x6c;&#x69;&#x7a;er&#112;&#46;&#99;&#111;&#x6d;<\/a>\n<\/p>\n<p>\n<b>Investors &#8211; ACTIFIN<\/b><br \/>Ghislaine Gasparetto<br \/>\n<br \/>+33 6 21 10 49 24<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;&#116;&#x6f;&#58;&#x67;&#103;&#x61;&#115;&#x70;&#97;&#x72;&#101;&#x74;&#116;&#x6f;&#64;&#x61;&#99;&#x74;&#105;&#x66;&#105;&#x6e;&#46;&#x66;r\" rel=\"nofollow noopener\" shape=\"rect\">&#103;&#x67;&#97;&#x73;p&#97;&#x72;&#101;&#x74;t&#x6f;&#64;&#97;&#x63;&#116;&#x69;f&#x69;&#x6e;&#46;&#x66;r<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>SOPHIA ANTIPOLIS, France&#8211;(BUSINESS WIRE)&#8211;Regulatory News: The shareholders of Median Technologies (ALMDT:PA) are invited to participate at the Shareholders\u2019 Ordinary and Extraordinary General Meeting which will be held on Tuesday June 14, 2022, at 5:00 PM at PDGB, 174 avenue Victor Hugo \u2013 75116 Paris. All useful information relating to this Shareholders\u2019 General Meeting is regularly &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/median-technologies-announces-the-availability-of-the-preparatory-documents-for-the-shareholders-ordinary-and-extraordinary-general-meeting-on-june-14-2022\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44228","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders\u2019 Ordinary and Extraordinary General Meeting on June 14, 2022 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/median-technologies-announces-the-availability-of-the-preparatory-documents-for-the-shareholders-ordinary-and-extraordinary-general-meeting-on-june-14-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders\u2019 Ordinary and Extraordinary General Meeting on June 14, 2022 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SOPHIA ANTIPOLIS, France&#8211;(BUSINESS WIRE)&#8211;Regulatory News: The shareholders of Median Technologies (ALMDT:PA) are invited to participate at the Shareholders\u2019 Ordinary and Extraordinary General Meeting which will be held on Tuesday June 14, 2022, at 5:00 PM at PDGB, 174 avenue Victor Hugo \u2013 75116 Paris. All useful information relating to this Shareholders\u2019 General Meeting is regularly ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/median-technologies-announces-the-availability-of-the-preparatory-documents-for-the-shareholders-ordinary-and-extraordinary-general-meeting-on-june-14-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-23T16:01:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220523005724\/en\/1343975\/21\/Median_RGB.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-announces-the-availability-of-the-preparatory-documents-for-the-shareholders-ordinary-and-extraordinary-general-meeting-on-june-14-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-announces-the-availability-of-the-preparatory-documents-for-the-shareholders-ordinary-and-extraordinary-general-meeting-on-june-14-2022\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders\u2019 Ordinary and Extraordinary General Meeting on June 14, 2022\",\"datePublished\":\"2022-05-23T16:01:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-announces-the-availability-of-the-preparatory-documents-for-the-shareholders-ordinary-and-extraordinary-general-meeting-on-june-14-2022\\\/\"},\"wordCount\":511,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-announces-the-availability-of-the-preparatory-documents-for-the-shareholders-ordinary-and-extraordinary-general-meeting-on-june-14-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220523005724\\\/en\\\/1343975\\\/21\\\/Median_RGB.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-announces-the-availability-of-the-preparatory-documents-for-the-shareholders-ordinary-and-extraordinary-general-meeting-on-june-14-2022\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-announces-the-availability-of-the-preparatory-documents-for-the-shareholders-ordinary-and-extraordinary-general-meeting-on-june-14-2022\\\/\",\"name\":\"Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders\u2019 Ordinary and Extraordinary General Meeting on June 14, 2022 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-announces-the-availability-of-the-preparatory-documents-for-the-shareholders-ordinary-and-extraordinary-general-meeting-on-june-14-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-announces-the-availability-of-the-preparatory-documents-for-the-shareholders-ordinary-and-extraordinary-general-meeting-on-june-14-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220523005724\\\/en\\\/1343975\\\/21\\\/Median_RGB.jpg\",\"datePublished\":\"2022-05-23T16:01:18+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-announces-the-availability-of-the-preparatory-documents-for-the-shareholders-ordinary-and-extraordinary-general-meeting-on-june-14-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-announces-the-availability-of-the-preparatory-documents-for-the-shareholders-ordinary-and-extraordinary-general-meeting-on-june-14-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-announces-the-availability-of-the-preparatory-documents-for-the-shareholders-ordinary-and-extraordinary-general-meeting-on-june-14-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220523005724\\\/en\\\/1343975\\\/21\\\/Median_RGB.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220523005724\\\/en\\\/1343975\\\/21\\\/Median_RGB.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-announces-the-availability-of-the-preparatory-documents-for-the-shareholders-ordinary-and-extraordinary-general-meeting-on-june-14-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders\u2019 Ordinary and Extraordinary General Meeting on June 14, 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders\u2019 Ordinary and Extraordinary General Meeting on June 14, 2022 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/median-technologies-announces-the-availability-of-the-preparatory-documents-for-the-shareholders-ordinary-and-extraordinary-general-meeting-on-june-14-2022\/","og_locale":"en_US","og_type":"article","og_title":"Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders\u2019 Ordinary and Extraordinary General Meeting on June 14, 2022 - Pharma Trend","og_description":"SOPHIA ANTIPOLIS, France&#8211;(BUSINESS WIRE)&#8211;Regulatory News: The shareholders of Median Technologies (ALMDT:PA) are invited to participate at the Shareholders\u2019 Ordinary and Extraordinary General Meeting which will be held on Tuesday June 14, 2022, at 5:00 PM at PDGB, 174 avenue Victor Hugo \u2013 75116 Paris. All useful information relating to this Shareholders\u2019 General Meeting is regularly ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/median-technologies-announces-the-availability-of-the-preparatory-documents-for-the-shareholders-ordinary-and-extraordinary-general-meeting-on-june-14-2022\/","og_site_name":"Pharma Trend","article_published_time":"2022-05-23T16:01:18+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220523005724\/en\/1343975\/21\/Median_RGB.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/median-technologies-announces-the-availability-of-the-preparatory-documents-for-the-shareholders-ordinary-and-extraordinary-general-meeting-on-june-14-2022\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/median-technologies-announces-the-availability-of-the-preparatory-documents-for-the-shareholders-ordinary-and-extraordinary-general-meeting-on-june-14-2022\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders\u2019 Ordinary and Extraordinary General Meeting on June 14, 2022","datePublished":"2022-05-23T16:01:18+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/median-technologies-announces-the-availability-of-the-preparatory-documents-for-the-shareholders-ordinary-and-extraordinary-general-meeting-on-june-14-2022\/"},"wordCount":511,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/median-technologies-announces-the-availability-of-the-preparatory-documents-for-the-shareholders-ordinary-and-extraordinary-general-meeting-on-june-14-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220523005724\/en\/1343975\/21\/Median_RGB.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/median-technologies-announces-the-availability-of-the-preparatory-documents-for-the-shareholders-ordinary-and-extraordinary-general-meeting-on-june-14-2022\/","url":"https:\/\/pharma-trend.com\/en\/median-technologies-announces-the-availability-of-the-preparatory-documents-for-the-shareholders-ordinary-and-extraordinary-general-meeting-on-june-14-2022\/","name":"Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders\u2019 Ordinary and Extraordinary General Meeting on June 14, 2022 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/median-technologies-announces-the-availability-of-the-preparatory-documents-for-the-shareholders-ordinary-and-extraordinary-general-meeting-on-june-14-2022\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/median-technologies-announces-the-availability-of-the-preparatory-documents-for-the-shareholders-ordinary-and-extraordinary-general-meeting-on-june-14-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220523005724\/en\/1343975\/21\/Median_RGB.jpg","datePublished":"2022-05-23T16:01:18+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/median-technologies-announces-the-availability-of-the-preparatory-documents-for-the-shareholders-ordinary-and-extraordinary-general-meeting-on-june-14-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/median-technologies-announces-the-availability-of-the-preparatory-documents-for-the-shareholders-ordinary-and-extraordinary-general-meeting-on-june-14-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/median-technologies-announces-the-availability-of-the-preparatory-documents-for-the-shareholders-ordinary-and-extraordinary-general-meeting-on-june-14-2022\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220523005724\/en\/1343975\/21\/Median_RGB.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220523005724\/en\/1343975\/21\/Median_RGB.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/median-technologies-announces-the-availability-of-the-preparatory-documents-for-the-shareholders-ordinary-and-extraordinary-general-meeting-on-june-14-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders\u2019 Ordinary and Extraordinary General Meeting on June 14, 2022"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44228","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44228"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44228\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44228"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44228"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44228"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}